Competitive Federalism and the Governance of Controversial Science
Michael Mintrom
Publius: The Journal of Federalism, 2009, vol. 39, issue 4, 606-631
Abstract:
Tensions between the United States government and state governments increased during the Bush Administration, 2001--2008. Blame was typically placed on the Administration's conservative policy preferences. This article analyzes how the issue of stem cell research was managed during those years in Washington, DC and how the states responded. The case highlights contradictions in the Bush Administration's brand of conservatism, how this promoted interstate competition, and why state governments had to wrestle with major policy dilemmas. Concerns surrounding moral principles, scientific progress, and economic competitiveness produced a patchwork of state funding and regulatory regimes. That outcome has not been ideal from several perspectives. Advances in biotechnology and other controversial areas of science will force future national and state governments to confront similar policymaking challenges. Copyright 2009, Oxford University Press.
Date: 2009
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
http://hdl.handle.net/10.1093/publius/pjn033 (application/pdf)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:oup:publus:v:39:y:2009:i:4:p:606-631
Ordering information: This journal article can be ordered from
https://academic.oup.com/journals
Access Statistics for this article
Publius: The Journal of Federalism is currently edited by Paul Nolette and Philip Rocco
More articles in Publius: The Journal of Federalism from CSF Associates Inc. Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK.
Bibliographic data for series maintained by Oxford University Press ().